Bausch Health Aktie [WKN DE: A2JQ1X / ISIN: CA0717341071]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Bausch Health

28.03.22		Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Asso... (PR Newswire)
24.03.22		New Data on Cost Impact of Treating Opioid-Induced Constipation (OIC) with FDA-Approved Medications, Including Salix's RELISTOR® Subcutaneous Injection (Methylnaltrexone Bromide), in The Emergency... (PR Newswire)
22.03.22		Gary Gemignani Will Join Solta Medical Corporation As Chief Financial Officer (PR Newswire)
22.03.22		Ortho Dermatologics Will Present New Data at the 2022 American Academy of Dermatology Annual Meeting (PR Newswire)
03.03.22		Bausch Health Announces Participation in Upcoming Investor Conferences (PR Newswire)
02.03.22		Ortho Dermatologics Now Accepting Applications for 2022 Aspire Higher Scholarship Program (PR Newswire)
01.03.22		Salix and Colon Cancer Coalition Join Forces for 'Faces of Blue' Story Series to Raise Awareness of Colorectal Cancer Screenings (PR Newswire)
24.02.22		Bausch Health Announces Participation At The J.P. Morgan Global High Yield & Leveraged Finance Conference (PR Newswire)
23.02.22		Bausch Health Companies Inc. Announces Fourth-Quarter And Full-Year 2021 Results And Provides 2022 Guidance (PR Newswire)
22.02.22		OraPharma Launches OraFit™ Custom Clear Dental Aligner System (PR Newswire)
15.02.22		Salix Announces 2022 Gastrointestinal Health Scholars Program (PR Newswire)
08.02.22		Solta Medical Corporation Files Registration Statement for Proposed Initial Public Offering (PR Newswire)
03.02.22		Bausch Health Companies Inc. Will Release Fourth-Quarter and Full-Year 2021 Financial Results on February 23 (PR Newswire)
01.02.22		BAUSCH + LOMB AND PREVENT BLINDNESS LAUNCH ANNUAL AMD AWARENESS MONTH CAMPAIGN TO EDUCATE PATIENTS (PR Newswire)
27.01.22		Bausch Health Announces Pricing Of Private Offering Of Senior Secured Notes (PR Newswire)
27.01.22		Bausch Health Announces Launch Of Private Offering Of Senior Secured Notes (PR Newswire)
20.01.22		Dr. Yehia Hashad Will Join Bausch + Lomb Corporation as Executive Vice President of Research & Development and Chief Medical Officer (PR Newswire)
18.01.22		Bausch Health Announces It Is Seeking To Refinance Its Existing Credit Agreement And Conditional Redemption Of Existing Notes - These Steps Will Enable Bausch + Lomb IPO And Facilitate Full Separation (PR Newswire)
13.01.22		Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering (PR Newswire)
11.01.22		Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)
05.01.22		BAUSCH HEALTH TO PARTICIPATE AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
04.01.22		NEW SURVEY FROM BAUSCH + LOMB AND GLAUCOMA RESEARCH FOUNDATION REVEALS EMOTIONAL AND SOCIAL IMPACT OF HYPEREMIA ON GLAUCOMA PATIENTS (PR Newswire)
22.12.21		RELISTOR® (METHYLNALTREXONE BROMIDE) DATA IS PUBLISHED IN THE JOURNAL OF EMERGENCY MEDICINE (PR Newswire)
06.12.21		APMA Grants Seal of Approval for JUBLIA® (efinaconazole) Topical Solution, 10% (PR Newswire)
03.12.21		Salix Brings Educational Resources on Constipation Into the Homes of Patients and Caregivers for Constipation Awareness Month (PR Newswire)
15.11.21		Bausch + Lomb Reports More Than 41 Million Units Of Contact Lens, Eye And Lens Care Materials Recycled Through ONE By ONE And Biotrue® Eye Care Recycling Programs (PR Newswire)
11.11.21		Salix Will Share New Rifaximin Data At AASLD's The Liver Meeting™ 2021 (PR Newswire)
04.11.21		Bausch Health Announces Participation In Upcoming Investor Conferences (PR Newswire)
02.11.21		Bausch Health Q3 Profit Climbs (RTTNews)
02.11.21		Bausch Health Companies Inc. Announces Third-Quarter 2021 Results (PR Newswire)
01.11.21		Bausch + Lomb Will Present Scientific Data and Analyses During the American Academy of Ophthalmology and American Academy of Optometry Annual Meetings (PR Newswire)
27.10.21		Bausch + Lomb Launches Biotrue® Eye Care Recycling Program in Collaboration With TerraCycle in the United States (PR Newswire)
25.10.21		New Report Reveals Barriers To Quality Care For Chronic Liver Disease Patients, A Cause Of Morbidity And Mortality Projected To Grow In The United States (PR Newswire)
25.10.21		Salix Will Feature New Data At The American College Of Gastroenterology® 2021 Annual Scientific Meeting (PR Newswire)
25.10.21		Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uv... (PR Newswire)
21.10.21		Bausch Health Announces Tom Vadaketh Will Join Bausch Pharma* As Chief Financial Officer (PR Newswire)
19.10.21		Ortho Dermatologics To Present New Data At The 2021 Fall Clinical Dermatology Conference (PR Newswire)
06.10.21		Bausch Health Companies Inc. Will Release Third-Quarter 2021 Financial Results On November 2 (PR Newswire)
30.09.21		Bausch + Lomb: Second Phase 3 Trial Reaffirms Safety & Efficacy Results For NOV03 (RTTNews)
30.09.21		Bausch + Lomb Announces Statistically Significant Topline Results from the Second Phase 3 Trial Of NOV03 (perfluorohexyloctane) in Dry Eye Disease Associated with Meibomian Gland Dysfunction (PR Newswire)
29.09.21		Bausch Health Releases Annual Environmental, Social and Governance Report (PR Newswire)
02.09.21		Salix Will Share RELISTOR® (Methylnaltrexone Bromide) Data At PAINWeek 2021 (PR Newswire)
01.09.21		Bausch Health Announces Participation In Upcoming Investor Conferences (PR Newswire)
12.08.21		SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC (PR Newswire)
04.08.21		Bausch Health : Health Canada Approves ARAZLO Lotion For Acne Vulgaris Treatment (RTTNews)
04.08.21		Health Canada Approves ARAZLO™ (Tazarotene) Lotion, 0.045%, First Such Lotion Treatment For Acne Vulgaris (PR Newswire)
04.08.21		SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Bausch Health Companies Inc. - BHC (PR Newswire)
03.08.21		Bausch Health Q2 Loss Widens; Plans To Pursue IPO Of Solta Medical Business (RTTNews)
03.08.21		Bausch Health Companies Inc. Announces Second-Quarter 2021 Results (PR Newswire)
03.08.21		Bausch Health Companies Inc. Announces Second-Quarter 2021 Results (PR Newswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Ripple auf dem Weg zu 100 US-Dollar in 2025?

Krypto-Rekorde voraus: Wall Street sieht Bitcoin bei 200.000 US-Dollar

EQS-Adhoc: STRABAG SE CEO Klemens Haselsteiner passed away completely unexpectedly

Ripple Kurs Prognose: 10 US-Dollar bis Ende des Jahres?

Diese Aktien empfehlen Experten zu kaufen

Trump ruft eigenen Krypto-Coin "$TRUMP" ins Leben - Kryptocoin auch für Melania

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2025 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	20.01.2025 17:59
Kaufwert:	EUR
	Hinzufügen Speichern